Literature DB >> 229727

Transfer of measles, mumps, and rubella antibodies from mother to infant. Its effect on measles, mumps, and rubella immunization.

H Sato, P Albrecht, D W Reynolds, S Stagno, F A Ennis.   

Abstract

Sera from 42 mother-infant pairs were examined to determine the effect of passively acquired enhanced neutralizing (ENt) antibody on immunization. The ENt antibodies to measles, mumps, and rubella were greater in term newborns than in their mothers, with mean ratio of 1.8:1, 1.3:1, and 1.2:1, respectively. In 21% to 25% of the children, these antibodies persisted until 12 months of age. When immunized with trivalent measles-mumps-rubella vaccine, children who had persisting ENt measles and rubella titers had significantly lower mean antibody responses than children without detectable antibodies to the two viruses. Persisting ENt mumps antibodies did not affect the postimmunization titers. Seroconversion rates to any of the three viruses were not different in children with or without preexisting ENt antibody.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 229727     DOI: 10.1001/archpedi.1979.02130120032005

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  24 in total

1.  IgG subclasses compared in maternal and cord serum and breast milk.

Authors:  A Gasparoni; A Avanzini; F Ravagni Probizer; G Chirico; G Rondini; F Severi
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

2.  Meningococcal antibody titres in infants of women immunised with meningococcal polysaccharide vaccine during pregnancy.

Authors:  T J O'Dempsey; T McArdle; S J Ceesay; O Secka; E Demba; W A Banya; N Francis; B M Greenwood
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-01       Impact factor: 5.747

3.  Prevalence of anti-rubella, anti-measles and anti-mumps IgG antibodies in neonates and pregnant women in Catalonia (Spain) in 2013: susceptibility to measles increased from 2003 to 2013.

Authors:  P Plans; F de Ory; M Campins; E Álvarez; T Payà; E Guisasola; C Compte; K Vellbé; C Sánchez; M J Lozano; I Aran; A Bonmatí; R Carreras; M Jané; L Cabero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-10       Impact factor: 3.267

4.  Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.

Authors:  B Schlereth; J K Rose; L Buonocore; V ter Meulen; S Niewiesk
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

5.  Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses.

Authors:  C Nicoara; K Zäch; D Trachsel; D Germann; L Matter
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

6.  Maternal mumps antibodies in a cohort of children up to the age of 1 year.

Authors:  E Leuridan; N Goeyvaerts; N Hens; V Hutse; P Van Damme
Journal:  Eur J Pediatr       Date:  2012-03-07       Impact factor: 3.183

7.  Half-life of the maternal IgG1 allotype in infants.

Authors:  H Sarvas; I Seppälä; S Kurikka; R Siegberg; O Mäkelä
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

8.  Viral antibodies in maternal and cord sera.

Authors:  T Gotlieb-Stematsky; I Meron; M Modan; Y Sayar; S Leventon-Kriss; A Fogel; R Gurewitz; V Insler
Journal:  Med Microbiol Immunol       Date:  1983       Impact factor: 3.402

9.  Public health implications of rubella antibody levels in California.

Authors:  L G Dales; J Chin
Journal:  Am J Public Health       Date:  1982-02       Impact factor: 9.308

10.  The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya.

Authors:  Rachel Ochola; Charles Sande; Gregory Fegan; Paul D Scott; Graham F Medley; Patricia A Cane; D James Nokes
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.